Keir Loiacono

Keir Loiacono, Esq.

Mr. Loiacono brings years of transactional experience from the biotech, pharmaceutical and medtech industries. A patent lawyer by training, Mr. Loiacono represented companies of various sizes in all stages of transactions, including licensing and M & A. As a seasoned life sciences executive in the oncology sector, he has extensive experience raising capital in the public capital market space and closed numerous deals including licenses, clinical collaborations and strategic transactions with significant upfront payments. Most recently, Mr. Loiacono was the Vice President of Business Development and General Counsel of OncoSec Medical Incorporated, a public, clinical-stage oncology company. He also currently serves on the Board of Directors for EpiAxis Therapuetics, an early-stage drug discovery company focusing on the LSD-1 pathway.